Host cell restriction factors of equine infectious anemia virus.


Journal

Virologica Sinica
ISSN: 1995-820X
Titre abrégé: Virol Sin
Pays: Netherlands
ID NLM: 101514185

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 13 04 2023
accepted: 03 07 2023
medline: 14 8 2023
pubmed: 8 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

Equine infectious anemia virus (EIAV) is a member of the lentivirus genus in the Retroviridae family and is considered an animal model for HIV/AIDS research. An attenuated EIAV vaccine, which was successfully developed in the 1970s by classical serial passage techniques, is the first and only lentivirus vaccine that has been widely used to date. Restriction factors are cellular proteins that provide an early line of defense against viral replication and spread by interfering with various critical steps in the viral replication cycle. However, viruses have evolved specific mechanisms to overcome these host barriers through adaptation. The battle between the viruses and restriction factors is actually a natural part of the viral replication process, which has been well studied in human immunodeficiency virus type 1 (HIV-1). EIAV has the simplest genome composition of all lentiviruses, making it an intriguing subject for understanding how the virus employs its limited viral proteins to overcome restriction factors. In this review, we summarize the current literature on the interactions between equine restriction factors and EIAV. The features of equine restriction factors and the mechanisms by which the EIAV counteract the restriction suggest that lentiviruses employ diverse strategies to counteract innate immune restrictions. In addition, we present our insights on whether restriction factors induce alterations in the phenotype of the attenuated EIAV vaccine.

Identifiants

pubmed: 37419416
pii: S1995-820X(23)00081-0
doi: 10.1016/j.virs.2023.07.001
pmc: PMC10436108
pii:
doi:

Substances chimiques

Antiviral Restriction Factors 0
Viral Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-496

Informations de copyright

Copyright © 2023 The Authors. Publishing services by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that there are no conflicts of interest.

Références

J Biol Chem. 2017 Jan 6;292(1):264-277
pubmed: 27909056
Vet Res. 2004 Jul-Aug;35(4):485-512
pubmed: 15236678
J Virol. 1993 Jul;67(7):4386-90
pubmed: 8510227
Nat Med. 2007 May;13(5):631-5
pubmed: 17435772
Traffic. 2003 Oct;4(10):694-709
pubmed: 12956872
Viruses. 2021 Mar 02;13(3):
pubmed: 33801276
J Biol Chem. 2020 Mar 27;295(13):4252-4264
pubmed: 32075911
Nat Struct Mol Biol. 2004 May;11(5):435-42
pubmed: 15098018
Biochemistry. 2020 Feb 11;59(5):652-662
pubmed: 31917549
Cell Host Microbe. 2008 Apr 17;3(4):245-52
pubmed: 18342597
Cell Host Microbe. 2013 Apr 17;13(4):441-51
pubmed: 23601106
Sci Rep. 2021 Oct 25;11(1):20984
pubmed: 34697376
Front Microbiol. 2014 Apr 10;5:163
pubmed: 24782851
J Virol. 2014 Mar;88(6):3255-72
pubmed: 24390322
Nature. 2002 Aug 8;418(6898):646-50
pubmed: 12167863
Nature. 2013 Oct 24;502(7472):559-62
pubmed: 24048477
Sci Rep. 2016 Dec 20;6:39507
pubmed: 27996044
J Virol. 2019 Jul 17;93(15):
pubmed: 31118262
Viruses. 2020 May 27;12(6):
pubmed: 32471198
Virology. 2021 Mar;555:78-88
pubmed: 33465725
PLoS Pathog. 2009 Feb;5(2):e1000300
pubmed: 19214216
Viruses. 2013 Dec 02;5(12):2963-76
pubmed: 24316675
Nature. 2015 Oct 8;526(7572):212-7
pubmed: 26416734
J Virol. 2014 Jan;88(2):1259-70
pubmed: 24227834
Front Microbiol. 2020 Apr 30;11:697
pubmed: 32431673
J Immunol. 2013 May 1;190(9):4736-41
pubmed: 23526823
Science. 2004 Mar 19;303(5665):1829
pubmed: 15031497
Cell Host Microbe. 2011 Dec 15;10(6):534-9
pubmed: 22177558
Oncotarget. 2017 Jul 31;8(40):68517-68529
pubmed: 28978134
Virology. 1996 Apr 1;218(1):159-68
pubmed: 8615019
Annu Rev Virol. 2018 Sep 29;5(1):323-340
pubmed: 30265629
Vet Microbiol. 2001 Mar 20;79(2):93-109
pubmed: 11230932
Emerg Microbes Infect. 2020 Dec;9(1):2030-2045
pubmed: 32873191
Virol Sin. 2019 Dec;34(6):725-728
pubmed: 31376080
Autophagy. 2021 Oct;17(10):2800-2817
pubmed: 33172327
Virology. 2006 May 25;349(1):22-30
pubmed: 16503341
Virus Res. 2011 Sep;160(1-2):274-82
pubmed: 21782860
Cell Host Microbe. 2009 Jul 23;6(1):54-67
pubmed: 19501037
Retrovirology. 2014 Dec 19;11:111
pubmed: 25524560
Nat Microbiol. 2019 Jun;4(6):933-940
pubmed: 30886358
J Equine Vet Sci. 2022 Jan;108:103795
pubmed: 34800799
J Biol Chem. 2009 Dec 11;284(50):35060-72
pubmed: 19837671
Arch Virol. 2016 Oct;161(10):2667-72
pubmed: 27383210
J Virol. 2023 Mar 30;97(3):e0021123
pubmed: 36916947
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13197-13202
pubmed: 27803322
J Virol. 1992 Oct;66(10):5906-13
pubmed: 1382143
Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):
pubmed: 35105802
Microbiol Mol Biol Rev. 2013 Dec;77(4):551-66
pubmed: 24296571
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2886-91
pubmed: 19179289
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5514-9
pubmed: 16540544
Nat Rev Immunol. 2004 Nov;4(11):868-77
pubmed: 15516966
J Gen Virol. 2007 Mar;88(Pt 3):998-1004
pubmed: 17325374
J Virol. 2008 Nov;82(21):10455-64
pubmed: 18768981
Nature. 2018 Jun;558(7711):610-614
pubmed: 29925952
J Virol. 2022 Sep 28;96(18):e0098622
pubmed: 36069548
J Virol. 2000 Jul;74(13):5968-81
pubmed: 10846078
J Virol. 1993 Sep;67(9):5640-6
pubmed: 8394464
Retrovirology. 2013 Feb 25;10:23
pubmed: 23442224
Animals (Basel). 2020 Nov 25;10(12):
pubmed: 33255568
Blood. 2012 Jul 26;120(4):778-88
pubmed: 22677126
J Biol Chem. 2019 Apr 26;294(17):7013-7024
pubmed: 30862674
Viruses. 2020 Feb 16;12(2):
pubmed: 32079099
Front Cell Dev Biol. 2022 Apr 01;10:856468
pubmed: 35433679
J Biol Chem. 2019 Oct 18;294(42):15346-15357
pubmed: 31444273
Mol Cell. 2022 May 5;82(9):1631-1642.e6
pubmed: 35316659
Virology. 2018 Oct;523:52-63
pubmed: 30081309
J Virol. 2022 Dec 21;96(24):e0121022
pubmed: 36448796
J Virol. 2020 Oct 27;94(22):
pubmed: 32907985
Genome Biol Evol. 2016 Dec 31;8(11):3508-3515
pubmed: 27797950
PLoS Pathog. 2020 Sep 28;16(9):e1008855
pubmed: 32986788
J Virol. 2017 Jan 31;91(4):
pubmed: 27928004
J Virol. 2013 Dec;87(24):13124-33
pubmed: 24067975
Natl Inst Anim Health Q (Tokyo). 1976 Spring;16(1):8-15
pubmed: 177894
Cell Rep. 2013 Apr 25;3(4):1036-43
pubmed: 23602554
J Biol Chem. 2017 Apr 7;292(14):6014-6026
pubmed: 28179429
Mol Cell Biol. 1989 Nov;9(11):5062-72
pubmed: 2481229
Retrovirology. 2012 Jun 26;9:55
pubmed: 22734835
J Virol. 2021 Nov 9;95(23):e0108721
pubmed: 34495693
J Virol. 2018 Mar 14;92(7):
pubmed: 29321318
Nature. 2015 Oct 8;526(7572):218-23
pubmed: 26416733
Cell Host Microbe. 2013 Oct 16;14(4):411-21
pubmed: 24139399
Virology. 2016 Aug;495:112-21
pubmed: 27200480
J Virol. 2006 Mar;80(5):2100-5
pubmed: 16474118
PLoS Pathog. 2011 May;7(5):e1002039
pubmed: 21625568
J Virol. 2018 Dec 10;93(1):
pubmed: 30333168
PLoS Pathog. 2013;9(7):e1003483
pubmed: 23874200
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8036-40
pubmed: 26080416
Microbiol Spectr. 2022 Feb 23;10(1):e0207321
pubmed: 35044222
Viruses. 2022 Feb 21;14(2):
pubmed: 35216035
J Cell Sci. 2013 Apr 1;126(Pt 7):1553-64
pubmed: 23378022
Microb Pathog. 2017 May;106:65-68
pubmed: 27816678
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13324-8
pubmed: 15326303
J Virol. 2009 Feb;83(4):1837-44
pubmed: 19036818
Nat Commun. 2018 May 17;9(1):1980
pubmed: 29773792
Nat Commun. 2021 Jul 28;12(1):4582
pubmed: 34321470
Nature. 2016 Dec 15;540(7633):448-452
pubmed: 27919079
Viruses. 2021 Mar 10;13(3):
pubmed: 33801908
Nature. 2008 Jan 24;451(7177):425-30
pubmed: 18200009
Retrovirology. 2012 Dec 11;9:105
pubmed: 23231760
PLoS Pathog. 2022 Oct 12;18(10):e1010907
pubmed: 36223419
Cell Rep. 2019 Jun 11;27(11):3269-3283.e6
pubmed: 31189110
Cell Host Microbe. 2007 Sep 13;2(3):193-203
pubmed: 18005734
J Virol. 2017 Apr 28;91(10):
pubmed: 28275190
J Virol. 2014 Nov;88(21):12296-310
pubmed: 25122784
Retrovirology. 2016 Feb 03;13:9
pubmed: 26842878
Emerg Microbes Infect. 2020 Dec;9(1):1309-1320
pubmed: 32525460
Cell Host Microbe. 2007 Aug 16;2(2):96-105
pubmed: 18005724
mBio. 2018 May 15;9(3):
pubmed: 29764952
J Virol. 2019 Jan 4;93(2):
pubmed: 30355687
Nat Microbiol. 2019 Dec;4(12):2260-2272
pubmed: 31548682
Transbound Emerg Dis. 2018 Feb;65(1):e7-e13
pubmed: 28503813
Cell Host Microbe. 2009 Mar 19;5(3):285-97
pubmed: 19286137
Antiviral Res. 2011 Nov;92(2):292-304
pubmed: 21893100
Nature. 2004 Feb 26;427(6977):848-53
pubmed: 14985764
J Virol. 2009 Nov;83(22):11966-78
pubmed: 19740980
Nature. 2011 May 25;474(7353):654-7
pubmed: 21613998
J Virol. 1998 Sep;72(9):7263-9
pubmed: 9696821
J Virol. 2008 Dec;82(23):11889-901
pubmed: 18818324
J Virol. 2019 Jun 14;93(13):
pubmed: 30996088
J Clin Invest. 2022 Dec 15;132(24):
pubmed: 36519538
Viruses. 2021 Jan 17;13(1):
pubmed: 33477360
Nature. 2013 Oct 24;502(7472):563-6
pubmed: 24121441
Viruses. 2020 Mar 31;12(4):
pubmed: 32244340
J Virol. 2011 Nov;85(21):11220-34
pubmed: 21835787
Proc Natl Acad Sci U S A. 2021 May 25;118(21):
pubmed: 34001619
PLoS Pathog. 2014 Mar 20;10(3):e1004024
pubmed: 24651717
Annu Rev Virol. 2020 Sep 29;7(1):421-446
pubmed: 32603630
J Virol. 2021 Apr 12;95(9):
pubmed: 33597208
PLoS Pathog. 2010 Apr 08;6(4):e1000856
pubmed: 20386718
J Virol. 2013 Nov;87(21):11516-24
pubmed: 23966382
Results Immunol. 2015 Oct 22;5:23-32
pubmed: 26623250
Front Cell Infect Microbiol. 2020 Jul 30;10:391
pubmed: 32850489
Cell. 2009 Oct 30;139(3):499-511
pubmed: 19879838
mBio. 2023 Apr 25;14(2):e0016123
pubmed: 36927083
AIDS. 2016 Aug 24;30(13):2053-64
pubmed: 27219130
Nature. 2012 Nov 1;491(7422):125-8
pubmed: 23000900
Vet Microbiol. 2013 Nov 29;167(1-2):181-204
pubmed: 24183747
J Cell Sci. 2007 Nov 1;120(Pt 21):3850-8
pubmed: 17940069
Front Microbiol. 2020 Sep 04;11:580233
pubmed: 33013817
J Biol Chem. 1986 Aug 25;261(24):11398-403
pubmed: 2426273
Cold Spring Harb Perspect Med. 2012 May;2(5):a006940
pubmed: 22553496
Front Immunol. 2018 Dec 06;9:2876
pubmed: 30574147
PLoS Pathog. 2022 Feb 9;18(2):e1009986
pubmed: 35139135
Cell Host Microbe. 2013 Oct 16;14(4):398-410
pubmed: 24055605
Nature. 2011 Jun 29;474(7353):658-61
pubmed: 21720370
Mol Cell. 2017 Oct 19;68(2):308-322.e4
pubmed: 28965816
Nat Commun. 2023 Jan 10;14(1):16
pubmed: 36627271
J Virol. 1994 Oct;68(10):6270-9
pubmed: 8083967
Brain. 2013 Jan;136(Pt 1):245-58
pubmed: 23365100
Nature. 2011 Nov 06;480(7377):379-82
pubmed: 22056990
J Biol Chem. 2018 Feb 23;293(8):2661-2674
pubmed: 29196608
J Virol. 2012 Jun;86(12):6688-700
pubmed: 22514338
J Virol. 2018 Aug 29;92(18):
pubmed: 29743377
Nat Commun. 2022 May 26;13(1):2935
pubmed: 35618710
Nucleic Acids Res. 2007;35(21):7096-108
pubmed: 17942420
J Virol. 2009 Aug;83(15):7547-59
pubmed: 19458006
Nat Commun. 2018 Jun 8;9(1):2227
pubmed: 29884836
Nature. 2003 Jul 3;424(6944):99-103
pubmed: 12808466
PLoS One. 2015 Sep 17;10(9):e0138190
pubmed: 26379128
Viruses. 2021 Jun 07;13(6):
pubmed: 34200141
Vaccine. 2006 Feb 6;24(6):738-49
pubmed: 16202485
Arch Virol. 2011 Feb;156(2):353-7
pubmed: 21136127
Nat Rev Immunol. 2008 Nov;8(11):849-60
pubmed: 18836477
mBio. 2022 Nov 21;13(6):e0292322
pubmed: 36409124
Viruses. 2021 Feb 28;13(3):
pubmed: 33671095
J Virol. 2017 Dec 14;92(1):
pubmed: 29046456

Auteurs

Xue-Feng Wang (XF)

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China.

Xiangmin Zhang (X)

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China.

Weiwei Ma (W)

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China.

Jiwei Li (J)

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China.

Xiaojun Wang (X)

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China. Electronic address: wangxiaojun@caas.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH